Mackenzie Financial’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $381K | Sell |
3,994
-10,198
| -72% | -$979K | ﹤0.01% | 1367 |
|
|
2026
Q1 | $1.47M | Sell |
14,192
-629
| -4% | -$71.3K | ﹤0.01% | 1004 |
|
|
2025
Q4 | $1.49M | Sell |
14,821
-52,709
| -78% | -$5.72M | ﹤0.01% | 956 |
|
|
2025
Q3 | $8.33M | Buy |
67,530
+44,252
| +190% | +$5.49M | 0.01% | 535 |
|
|
2025
Q2 | $2.79M | Buy |
23,278
+8,681
| +59% | +$1.16M | ﹤0.01% | 719 |
|
|
2025
Q1 | $2.15M | Buy |
14,597
+1,133
| +8% | +$173K | ﹤0.01% | 764 |
|
|
2024
Q4 | $2.19M | Buy |
13,464
+3,148
| +31% | +$515K | ﹤0.01% | 755 |
|
|
2024
Q3 | $1.68M | Sell |
10,316
-11,794
| -53% | -$1.75M | ﹤0.01% | 766 |
|
|
2024
Q2 | $3.02M | Sell |
22,110
-17,959
| -45% | -$2.49M | ﹤0.01% | 639 |
|
|
2024
Q1 | $6.13M | Sell |
40,069
-13,183
| -25% | -$1.97M | 0.01% | 526 |
|
|
2023
Q4 | $7.59M | Sell |
53,252
-109,811
| -67% | -$14.6M | 0.01% | 475 |
|
|
2023
Q3 | $21.2M | Sell |
163,063
-15,072
| -8% | -$2.29M | 0.04% | 305 |
|
|
2023
Q2 | $28.6M | Buy |
178,135
+94,929
| +114% | +$15.3M | 0.04% | 275 |
|
|
2023
Q1 | $13.2M | Buy |
83,206
+1,279
| +2% | +$192K | 0.02% | 397 |
|
|
2022
Q4 | $11.5M | Buy |
81,927
+6,337
| +8% | +$899K | 0.02% | 388 |
|
|
2022
Q3 | $9.71M | Sell |
75,590
-13,422
| -15% | -$1.94M | 0.02% | 418 |
|
|
2022
Q2 | $12.5M | Sell |
89,012
-2,981
| -3% | -$426K | 0.02% | 399 |
|
|
2022
Q1 | $12.8M | Buy |
91,993
+3,446
| +4% | +$528K | 0.02% | 432 |
|
|
2021
Q4 | $15.4M | Buy |
88,547
+3,414
| +4% | +$569K | 0.02% | 403 |
|
|
2021
Q3 | $14.1M | Buy |
85,133
+9,351
| +12% | +$1.61M | 0.02% | 404 |
|
|
2021
Q2 | $13.6M | Buy |
75,782
+7,253
| +11% | +$1.32M | 0.02% | 404 |
|
|
2021
Q1 | $13.2M | Buy |
68,529
+26,748
| +64% | +$5.15M | 0.02% | 378 |
|
|
2020
Q4 | $8.44M | Sell |
41,781
-1,328
| -3% | -$275K | 0.02% | 369 |
|
|
2020
Q3 | $9.06M | Sell |
43,109
-17,127
| -28% | -$3.81M | 0.02% | 317 |
|
|
2020
Q2 | $13.2M | Buy |
60,236
+46,018
| +324% | +$9.19M | 0.04% | 268 |
|
|
2020
Q1 | $2.46M | Sell |
14,218
-1,536
| -10% | -$254K | 0.01% | 463 |
|
|
2019
Q4 | $2.42M | Buy |
15,754
+698
| +5% | +$104K | 0.01% | 578 |
|
|
2019
Q3 | $2.29M | Sell |
15,056
-2,608
| -15% | -$412K | 0.01% | 589 |
|
|
2019
Q2 | $2.71M | Sell |
17,664
-918
| -5% | -$140K | 0.01% | 569 |
|
|
2019
Q1 | $2.98M | Buy |
18,582
+6,015
| +48% | +$933K | 0.01% | 680 |
|
|
2018
Q4 | $1.94M | Buy |
12,567
+5,146
| +69% | +$802K | 0.01% | 709 |
|
|
2018
Q3 | $1.12M | Buy |
7,421
+3,031
| +69% | +$431K | ﹤0.01% | 739 |
|
|
2018
Q2 | $594K | Buy |
4,390
+239
| +6% | +$29.5K | ﹤0.01% | 756 |
|
|
2018
Q1 | $553K | Buy |
4,151
+867
| +26% | +$116K | ﹤0.01% | 718 |
|
|
2017
Q4 | $488K | Sell |
3,284
-961
| -23% | -$131K | ﹤0.01% | 691 |
|
|
2017
Q3 | $560K | Buy |
4,245
+245
| +6% | +$32.9K | ﹤0.01% | 510 |
|
|
2017
Q2 | $533K | Buy |
4,000
+1,041
| +35% | +$140K | ﹤0.01% | 511 |
|
|
2017
Q1 | $399K | Sell |
2,959
-1,712
| -37% | -$222K | ﹤0.01% | 546 |
|
|
2016
Q4 | $561K | Buy |
4,671
+1,618
| +53% | +$191K | ﹤0.01% | 502 |
|
|
2016
Q3 | $382K | Sell |
3,053
-827
| -21% | -$108K | ﹤0.01% | 532 |
|
|
2016
Q2 | $537K | Sell |
3,880
-5,845
| -60% | -$758K | ﹤0.01% | 745 |
|
|
2016
Q1 | $1.23M | Sell |
9,725
-1,872
| -16% | -$238K | 0.01% | 458 |
|
|
2015
Q4 | $1.47M | Buy |
11,597
+5,176
| +81% | +$642K | 0.01% | 470 |
|
|
2015
Q3 | $742K | Buy |
6,421
+4,422
| +221% | +$496K | ﹤0.01% | 593 |
|
|
2015
Q2 | $208K | Buy |
+1,999
| New | +$216K | ﹤0.01% | 804 |
|
Other funds holding CLX
Mackenzie Financial's CLX Position: Q2 2026 in Review
Mackenzie Financial reduced its Clorox (CLX) stake by 72% in Q2 2026, selling an estimated $979K and leaving 3,994 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.
Mackenzie Financial first reported a position in CLX in Q2 2015 and has held it in 45 quarters since. The position peaked at $28.6M in Q2 2023. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Mackenzie Financial held 3,994 shares of Clorox worth $381K as of Q2 2026.
- Mackenzie Financial sold 10,198 Clorox shares in Q2 2026, an estimated $979K.
- Clorox made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1367 holding.
- Mackenzie Financial first reported a position in Clorox in Q2 2015 and has held it in 45 quarters since.
- Mackenzie Financial's Clorox position peaked at $28.6M in Q2 2023.
- 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.